Medical Scientists gets funds for predictive tool:
This article was originally published in Clinica
Executive Summary
Predictive modelling software company Medical Scientists has secured $2.3m in private financing, which it will use to expand its sales and marketing programmes. The Boston, Massachusetts-based company's MediSave uses disease-specific information and biological data to forecast how many individuals may be affected with a specific disease and how much this will cost a health plan. The company's Hybrid product is used to identify who is likely to experience expensive health problems.
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.